论文部分内容阅读
为探讨石棉肺的早期诊断及药物治疗疗效考核指标,我们进行了石棉肺患者血清溶菌酶(LZM)、血管紧张素Ⅰ转换酶(ACE)及铜蓝蛋白(CP)活性测定,以了解石棉肺生化指标改变状况,现将结果介绍如下。
In order to explore the early diagnosis of asbestosis and the evaluation index of drug therapy efficacy, we performed the determination of serum Lysozyme (LZM), Angiotensin I Converting Enzyme (ACE) and Ceruloplasmin (CP) activity in asbestosis patients, Biochemical indicators change the status, the results are as follows.